This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. Activity code: H00025047. Approval Number: 170000053.
- Contact hours:
- Pharmacotherapy hours: 3
- Expiration date: December 1, 2017
- Course price: $10
Annual review of the impact of influenza, seasonal and pandemic. Includes epidemiology, virus types and subtypes, how influenza viruses drift and shift, and a look at the devastation caused by the 1918–1919 worldwide influenza pandemic. Discusses the goal of universal vaccination, diagnosis and treatment, and the composition of the 2016–2017 vaccines for prevention of seasonal influenza.
ATrain Education, Inc. is an approved provider by the American Occupational Therapy Association. The following course information applies to occupational therapy professionals:
- Target Audience: Occupational Therapists, OTAs
- Instructional Level: Intermediate
- Content Focus: Content Focus:
• Category 1—Domain of OT, Client Factors
• Category 2—Occupational Therapy Process, Outcomes
Criteria for Successful Completion
80% or higher on the post test, a completed evaluation form, and payment where required. No partial credit will be awarded.
Conflict of Interest/Commercial Support
Objectives: When you finish this course you will be able to:
- Describe the annual global incidence of seasonal flu worldwide.
- State 2 characteristics each of influenza A, B, and C.
- Define antigenic drift and antigenic shift.
- Describe 3 characteristics of pandemic influenza.
- Identify the 5 “classic” clinical features of seasonal influenza.
- State the vaccination rate goal for healthcare providers under Healthy People 2020.
- Describe 3 reasons why healthcare providers refuse or fail to receive a seasonal influenza vaccination.
- Summarize the purpose of antiviral medications in the treatment of flu.
- State the 5 key influenza prevention strategies that should be practiced in all long-term care settings.
- Describe the 4 types of trivalent inactivated influenza vaccine that are approved for the 2016–2017 season.
- Explain the makeup of the 2016–2017 influenza vaccine.